Hematopoietic stem cells (HSCs) give rise to all blood cells and their progenies and reside in a special microenvironment in the bone marrow (BM) [
1]. Under physiological conditions, most HSCs are quiescent, and only a small fraction of HSCs enters the cell cycle and differentiates into multipotent progenitors [
2,
3,
4,
5,
6]. Intrinsic or extrinsic signals induce the differentiation of these progenitors to common lymphoid and myeloid progenitors under the so-called process of hematopoiesis [
7]. In hematological malignancies, aberrations in the bone marrow microenvironment limit the regeneration and differentiation potential of HSCs by reducing their numbers and/or function [
8]. Therefore, the hematopoietic system is well-organized in a hierarchical differentiation cascade, where each phase in the differentiation process requires a different combination of cytokines, chemokines, extracellular matrix (ECM) interactions and cell-cell interactions, which are offered by different stromal cell types [
9]. Mesenchymal stem cells (MSCs) are the pivotal stromal cellular players of the endosteal niche. They are in intimate interaction with HSCs, maintaining their stem cell quiescence, self-renewal, apoptosis and differentiation properties through the production of cytokines, chemokines, and ECM [
3]. Several studies have shown that the indirect interaction between MSCs and HSCs is maintained by the secretion of thrombopoietin (TPO), stem cell factor (SCF), and fms-like tyrosine kinase 3/fetal liver kinase-2 (FLT3/Flk2) cytokines that regulate the function of HSCs [
10,
11]. Moreover, MSCs possess C-X-C motif chemokine 12/ stromal-derived factor 1 (CXCL12/SDF1), SCF/c-Kit and Slit-2/Robo-4 chemokines which play a role in the trafficking and homing of HSCs [
2,
4,
5,
12,
13]. In addition to the production of a large array of regulatory molecules, recent studies document the role of MSCs in affecting the function of HSCs through direct contact [
7,
14]. Communication of cells by cellular contacts could be mediated through gap junctions which are membrane proteins that mediate exchanges of small molecules (<1KDa), secondary messengers, and ions between various cells, for example, Ca
2+, cyclic adenosine monophosphate (cAMP), and inositol triphosphate (IP3) [
15]. Cell-cell communication through gap junctions between HSCs and MSCs or stromal cells in the hematopoietic microenvironment of the human system is sparse. Yet, functional connexin (Cx)-43 gap junctions exist between stromal cells and immature hematopoietic progenitor cells in humans [
16], and Cx-43 and Cx-37 mRNA are expressed at low levels in human BM and cord blood hematopoietic progenitor CD34
+ cells [
15,
17]. This provides evidence of an important regulatory pathway of hematopoiesis through gap junctions in humans. Studies have shown that cadherins are major cell adhesion molecules responsible for Ca
2+-dependent cell-cell interaction [
18,
19]. The association between gap junctions and adherens junctions, particularly between Cx43 and N-cadherin, is required for gap junction assembly and function [
20]. The role of N-cadherin in HSCs-BM niche interactions is debatable. While some studies showed that N-cadherin conditional knockout mice had no observable phenotype in HSCs maintenance and hematopoiesis [
21], others demonstrated that the inhibition of N-cadherin expression reduced the anchoring of HSCs to the endosteal surface and inhibited their long-term engraftment [
22].
Intercellular communication with stromal cells affects AML cell proliferation, apoptosis [
25] and increases their drug resistance [
26], thus promoting AML relapse [
27]. Weber et al. demonstrated that the direct interaction of human myeloid leukemia cell lines with BM stromal cells decreased leukemic cell differentiation [
28]. Recently, a study showed that gap junction inhibition reduced chemoresistance to cytarabine, used in standard chemotherapy regimens against AML [
17] in BM-MSCs. Moreover, the disruption of gap junction interaction between AML cells and stromal cells, by carbenoxolone (a gap junction inhibitor), abridged the induced-chemoresistance by MSCs, suggesting the important role of gap junctions in AML chemoresistance [
28].